Parkinnova Therapeutics Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $384K

  • Investors
  • 5

Parkinnova Therapeutics General Information

Description

Operator of a therapeutic research center intended to find treatments for Parkinson's disease. The company aims to develop a sustainable and effective treatment, enabling parkinson's patients with a sustainable alternative to conventional treatments that addresses both motor symptoms and disease progression.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Science Park 904
  • 1098 XH Amsterdam
  • Netherlands
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Science Park 904
  • 1098 XH Amsterdam
  • Netherlands

Parkinnova Therapeutics Timeline

20252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Parkinnova Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 17-Apr-2025 $384K Completed Generating Revenue
3. Grant 18-Dec-2024 Completed Generating Revenue
2. Early Stage VC 30-Jan-2024 Completed Generating Revenue
1. University Spin-Out 01-Jan-2024 Completed Startup
To view Parkinnova Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Parkinnova Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Parkinnova Therapeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innovatiefonds Noord-Holland Venture Capital Minority
Netherlands Organisation for Scientific Research (Netherlands) Government
Amsterdam Academic Ventures Venture Capital Minority
UvA Ventures Holding Venture Capital Minority
University of Amsterdam University
To view Parkinnova Therapeutics’s complete investors history, request access »

Parkinnova Therapeutics FAQs

  • When was Parkinnova Therapeutics founded?

    Parkinnova Therapeutics was founded in 2024.

  • Where is Parkinnova Therapeutics headquartered?

    Parkinnova Therapeutics is headquartered in Amsterdam, Netherlands.

  • What is the size of Parkinnova Therapeutics?

    Parkinnova Therapeutics has 3 total employees.

  • What industry is Parkinnova Therapeutics in?

    Parkinnova Therapeutics’s primary industry is Drug Delivery.

  • Is Parkinnova Therapeutics a private or public company?

    Parkinnova Therapeutics is a Private company.

  • What is Parkinnova Therapeutics’s current revenue?

    The current revenue for Parkinnova Therapeutics is .

  • How much funding has Parkinnova Therapeutics raised over time?

    Parkinnova Therapeutics has raised $384K.

  • Who are Parkinnova Therapeutics’s investors?

    Innovatiefonds Noord-Holland, Netherlands Organisation for Scientific Research (Netherlands), Amsterdam Academic Ventures, UvA Ventures Holding, and University of Amsterdam have invested in Parkinnova Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process